Table 3. The relationship between TACI expression level and clinicopathologic feature.

Clinicopathologic feature	Cases (n)	TACI		P value
		Low-expression (n=)	High-expression (n=)
Age
≤60	34	21	13	0.3159
>60	38	19	19
Sex
male	46	23	23	0.7656
female	28	15	13
Grades
I-II	45	23	22	0.6106
III	10	6	4
Pathological Classification
adenocarcinoma	29	18	11	0.0271
squamous cell carcinoma	30	10	20